Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
PGENthis companyPrecigen, Inc.	$4.73	-2.96×	60.91×	131.52×	-5.51×	-112.7%	37.1%	-1100.8%	-2588.2%	-1198.6%	-88.5%	-7.1%	4.7×	-0.28×	-27.57×	3.09×	0.0%	4	-12.06	1	D+
ABEOAbeona Therapeutics Inc.	$2.65	3.93×	1.75×	47.95×	2.87×	-76.4%	73.7%	-1536.9%	1223.1%	44.7%	-44.0%	-30.2%	0.16×	-0.68×	-23.92×	6.93×	0.0%	2	-3.55	2	C
DTILPrecision BioSciences, Inc.	$10.57	-1.17×	0.58×	1.56×	0.68×	-257.3%	100.0%	-152.2%	-133.4%	-49.6%	-35.5%	-123.6%	0.31×	1.93×	-36.67×	13.32×	0.0%	3	-4.84	1	C-
EDITEditas Medicine, Inc.	$2.81	-1.14×	6.67×	4.49×	-0.75×	-308.6%	100.0%	-245.2%	-395.0%	-586.6%	-65.6%	-91.2%	2.81×	0.47×	-16.1×	3.54×	0.0%	3	-8.13	2	C
GNPXGenprex, Inc.	$2.09	-0.1×	0.21×	0×	0.4×	7438.7%	0.0%	0.0%	0.0%	-203.8%	-194.3%	-938.0%	0×	0.51×	-20.97×	3.84×	0.0%	2	-16.5	2	B-
MGXMetagenomi, Inc. Common Stock	$0.73	-0.69×	0.38×	2.39×	-0.72×	-11909.0%	78.9%	-380.9%	-348.5%	-55.4%	-47.0%	-148.3%	0.26×	0.01×	0×	7.22×	0.0%	2	-3.67	2	C
Peer median	—	-0.69×	0.58×	2.39×	0.4×	-257.3%	78.9%	-245.2%	-133.4%	-55.4%	-47.0%	-123.6%	0.26×	0.47×	-20.97×	6.93×	0.0%	2	-4.84	2	—